B
01875
BioDlink International
2.50
0.40+19.05%Closed12:08 12/24 HKT
OPEN/PREV CLOSE2.140/2.100
TODAY RANGE2.140-2.800
VOL1.48M
MARKET CAP1.93B
52 WEEK RANGE1.480-2.940
AVG VOL (3M)184.28K
% TURNOVER0.19%
TURNOVER3.73M
P/E (TTM)-438.596
% RANGE31.43%
EPS(TTM)-0.006
P/E(FORWARD)15.679
P/B2.408
BVPS1.038
DIVIDEND--
P/S1.936
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.93B
SHARES OUTSTANDING772.79M
NEXT EARNINGS03/09-03/13
FREE FLOAT772.79M
LOT SIZE400
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·11/18 23:15
Is BioDlink International (HKG:1875) Using Too Much Debt?
Reuters·11/11 10:03
TOT BIOPHARM INTERNATIONAL 9M REVENUE RMB 621.67 MILLION
Reuters·10/13 08:43
TOT BIOPHARM International Co Ltd files list of directors to HKEX
Simply Wall St·09/10 07:46
BioDlink International Company Limited's (HKG:1875) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Reuters·08/12 13:46
TOT BIOPHARM INTERNATIONAL H1 NET INCOME RMB 4.062 MILLION
Simply Wall St·07/24 00:09
Benign Growth For TOT BIOPHARM International Company Limited (HKG:1875) Underpins Its Share Price
Simply Wall St·06/13 22:53
TOT BIOPHARM International Company Limited's (HKG:1875) CEO Will Probably Find It Hard To See A Huge Raise This Year
Reuters·05/12 10:59
TOT BIOPHARM INTERNATIONAL Q1 REVENUE RMB 252.2 MILLION
Simply Wall St·05/05 00:27
TOT BIOPHARM International Full Year 2024 Earnings: EPS: CN¥0.048 (vs CN¥0.052 loss in FY 2023)
Simply Wall St·04/10 23:14
Is TOT BIOPHARM International (HKG:1875) A Risky Investment?
Reuters·03/11 14:47
TOT BIOPHARM INTERNATIONAL FY NET INCOME RMB -34.757 MILLION
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email : service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.